Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1481-1501
Published online before print February 19, 2007, doi: 10.1161/CIRCULATIONAHA.107.181546
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement: Evidence Summary Tables
Right arrow Correction (v115,pe407)
Right arrow All Versions of this Article:
115/11/1481    most recent
CIRCULATIONAHA.107.181546v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosca, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosca, L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Women's Health
Related Collections
Right arrow Primary prevention
Right arrow AHA Statements and Guidelines
Right arrow Epidemiology

(Circulation. 2007;115:1481-1501.)
© 2007 American Heart Association, Inc.


AHA Guideline

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update

Lori Mosca, MD, MPH, PhD, Chair; Carole L. Banka, PhD; Emelia J. Benjamin, MD; Kathy Berra, MSN, NP; Cheryl Bushnell, MD; Rowena J. Dolor, MD, MHS; Theodore G. Ganiats, MD; Antoinette S. Gomes, MD; Heather L. Gornik, MD, MHS; Clarissa Gracia, MD, MSCE; Martha Gulati, MD, MS; Constance K. Haan, MD; Debra R. Judelson, MD; Nora Keenan, PhD; Ellie Kelepouris, MD; Erin D. Michos, MD; L. Kristin Newby, MD, MHS; Suzanne Oparil, MD; Pamela Ouyang, MD; Mehmet C. Oz, MD; Diana Petitti, MD, MPH; Vivian W. Pinn, MD; Rita F. Redberg, MD, MSc; Rosalyn Scott, MD; Katherine Sherif, MD; Sidney C. Smith, Jr, MD; George Sopko, MD, MPH; Robin H. Steinhorn, MD; Neil J. Stone, MD; Kathryn A. Taubert, PhD; Barbara A. Todd, MSN, CRNP; Elaine Urbina, MD; Nanette K. Wenger, MD, for the Expert Panel/Writing Group*

*Representing the following participating organizations and major cosponsors: the American Heart Association (L.M., C.L.B., E.J.B., K.B., C.B., R.J.D., A.S.G., H.L.G., E.K., E.D.M., L.K.N., S.O., P.O., M.C.O., R.F.R., R.H.S., N.J.S., K.A.T., E.U., N.K.W.), American Academy of Family Physicians (T.G.G.), American College of Obstetricians and Gynecologists (C.G.), American College of Cardiology Foundation (M.G.), Society of Thoracic Surgeons (C.K.H.), American Medical Women’s Association (D.R.J.), Centers for Disease Control and Prevention (N.K.), Ad Hoc Writing Group Member (D.P.), Office of Research on Women’s Health (V.W.P.), Association of Black Cardiologists (R.S.), American College of Physicians (K.S.),{dagger} World Heart Federation (S.C.S.), National Heart, Lung, and Blood Institute (G.S.), and American College of Nurse Practitioners (B.A.T.).


Key Words: AHA Scientific Statements • women • cardiovascular diseases • prevention • risk factors


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Worldwide, cardiovascular disease (CVD) is the largest single cause of death among women, accounting for one third of all deaths.1 In many countries, including the United States, more women than men die every year of CVD, a fact largely unknown by physicians.2,3 The public health impact of CVD in women is not related solely to the mortality rate, given that advances in science and medicine allow many women to survive heart disease. For example, in the United States, 38.2 million women (34%) are living with CVD, and the population at risk is even larger.2 In China, a country with a population of approximately 1.3 billion, the age-standardized prevalence rates of dyslipidemia and hypertension in women 35 to 74 years of age are 53% and 25%, respectively, which underscores the enormity of CVD as a global health issue and the need for prevention of risk factors in the first place.4 As life expectancy continues to increase and economies become more industrialized, the burden of CVD on women and the global economy will continue to increase.5

The human toll and economic impact of CVD are difficult to overstate. In the United States alone, $403 billion was estimated to be spent in 2006 on health care or in lost productivity as a result of CVD, compared with $190 billion for cancer and $29 billion for human immunodeficiency virus (HIV).2 In addition to population-based and macroeconomic interventions, interventions in individual patients are key to reducing the incidence of CVD globally.6 Prevention of CVD is . . . [Full Text of this Article]


Find additional patient-related information at:

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update


This article has been cited by other articles:


Home page
NEJMHome page
A. J. Taylor, T. C. Villines, E. J. Stanek, P. J. Devine, L. Griffen, M. Miller, N. J. Weissman, and M. Turco
Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
N. Engl. J. Med., November 26, 2009; 361(22): 2113 - 2122.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, S. Mora, et al.
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1364 - 1405.
[Full Text] [PDF]


Home page
CirculationHome page
WRITING COMMITTEE MEMBERS, R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, et al.
ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research
Circulation, September 29, 2009; 120(13): 1296 - 1336.
[Full Text] [PDF]


Home page
CirculationHome page
A. K. Marma and D. M. Lloyd-Jones
Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile
Circulation, August 4, 2009; 120(5): 384 - 390.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
P. S. Douglas, A. Taylor, D. Bild, R. Bonow, P. Greenland, M. Lauer, F. Peacock, and J. Udelson
Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute
J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 897 - 907.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
P. S. Douglas, A. Taylor, D. Bild, R. Bonow, P. Greenland, M. Lauer, F. Peacock, and J. Udelson
Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute
Circ Cardiovasc Imaging, July 1, 2009; 2(4): 339 - 348.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
S. C. Folta, A. H. Lichtenstein, R. A. Seguin, J. P. Goldberg, J. F. Kuder, and M. E. Nelson
The StrongWomen-Healthy Hearts Program: Reducing Cardiovascular Disease Risk Factors in Rural Sedentary, Overweight, and Obese Midlife and Older Women
Am J Public Health, July 1, 2009; 99(7): 1271 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Gulati, R. M. Cooper-DeHoff, C. McClure, B. D. Johnson, L. J. Shaw, E. M. Handberg, I. Zineh, S. F. Kelsey, M. F. Arnsdorf, H. R. Black, et al.
Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project
Arch Intern Med, May 11, 2009; 169(9): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H. Ashikaga and J. E Marine
Prevention of atrial fibrillation: another good reason to recommend statins to women?
Heart, May 1, 2009; 95(9): 693 - 694.
[Full Text] [PDF]


Home page
StrokeHome page
E. M. Stuart-Shor, G. A. Wellenius, D. M. DelloIacono, and M. A. Mittleman
Gender Differences in Presenting and Prodromal Stroke Symptoms
Stroke, April 1, 2009; 40(4): 1121 - 1126.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. D. Michos and R. S. Blumenthal
Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
J. Am. Coll. Cardiol., March 17, 2009; 53(11): 931 - 935.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. J. Gibbons, A. Fugh-Berman, P. S. Chan, B. K. Nallamothu, R. A. Hayward, E. R. Jenny-Avital, K.-H. Mak, E. S.-Y. Chan, L. A. Pierard, C. E. Davis, et al.
Rosuvastatin in Patients with Elevated C-Reactive Protein
N. Engl. J. Med., March 5, 2009; 360(10): 1038 - 1042.
[Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
S. Mora
Aspirin Therapy in Women: Back to the ABCs
Circ Cardiovasc Qual Outcomes, March 1, 2009; 2(2): 63 - 64.
[Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
J. S. Berger, D. L. Brown, G. L. Burke, A. Oberman, J. B. Kostis, R. D. Langer, N. D. Wong, and S. Wassertheil-Smoller
Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease: The Women's Health Initiative Observational Study
Circ Cardiovasc Qual Outcomes, March 1, 2009; 2(2): 78 - 87.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
A. K. Jacobs
Coronary Intervention in 2009: Are Women No Different Than Men?
Circ Cardiovasc Interv, February 1, 2009; 2(1): 69 - 78.
[Full Text] [PDF]


Home page
CirculationHome page
J. D. Berry, K. Liu, A. R. Folsom, C. E. Lewis, J. J. Carr, J. F. Polak, S. Shea, S. Sidney, D. H. O'Leary, C. Chan, et al.
Prevalence and Progression of Subclinical Atherosclerosis in Younger Adults With Low Short-Term but High Lifetime Estimated Risk For Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis
Circulation, January 27, 2009; 119(3): 382 - 389.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Dey, M D Flather, G Devlin, D Brieger, E P Gurfinkel, P G Steg, G FitzGerald, E A Jackson, K A Eagle, and for the GRACE investigators
Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
Heart, January 1, 2009; 95(1): 20 - 26.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. M. Krumholz, J. L. Anderson, B. L. Bachelder, F. M. Fesmire, S. D. Fihn, J. M. Foody, P. M. Ho, M. N. Kosiborod, F. A. Masoudi, and B. K. Nallamothu
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) Developed in Collaboration With the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine
J. Am. Coll. Cardiol., December 9, 2008; 52(24): 2046 - 2099.
[Full Text] [PDF]


Home page
CirculationHome page
WRITING COMMITTEE MEMBERS, H. M. Krumholz, J. L. Anderson, B. L. Bachelder, F. M. Fesmire, S. D. Fihn, J. M. Foody, P. M. Ho, M. N. Kosiborod, F. A. Masoudi, et al.
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction): Developed in Collaboration With the American Academy of Family Physicians and the American College of Emergency Physicians: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine
Circulation, December 9, 2008; 118(24): 2596 - 2648.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
N. Collins, A. P. Tighe, S. A. Brunton, and P. M. Kris-Etherton
Differences between Dietary Supplement and Prescription Drug Omega-3 Fatty Acid Formulations: A Legislative and Regulatory Perspective
J. Am. Coll. Nutr., December 1, 2008; 27(6): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. McGeechan, P. Macaskill, L. Irwig, G. Liew, and T. Y. Wong
Assessing New Biomarkers and Predictive Models for Use in Clinical Practice: A Clinician's Guide
Arch Intern Med, November 24, 2008; 168(21): 2304 - 2310.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
L. Mosca, H. Mochari, M. Liao, A. H. Christian, D. J. Edelman, B. Aggarwal, and M. C. Oz
A Novel Family-Based Intervention Trial to Improve Heart Health: FIT Heart: Results of a Randomized Controlled Trial
Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 98 - 106.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. L. Bhatt, J. Scheiman, N. S. Abraham, E. M. Antman, F. K.L. Chan, C. D. Furberg, D. A. Johnson, K. W. Mahaffey, E. M. Quigley, R. A. Harrington, et al.
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1502 - 1517.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, D. L. Bhatt, J. Scheiman, N. S. Abraham, E. M. Antman, F. K.L. Chan, C. D. Furberg, D. A. Johnson, K. W. Mahaffey, and E. M. Quigley
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Circulation, October 28, 2008; 118(18): 1894 - 1909.
[Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
K. K. Pettee, K. L. Storti, M. B. Conroy, and B. E. Ainsworth
A Lifestyle Approach for Primary Cardiovascular Disease Prevention in Perimenopausal to Early Postmenopausal Women
American Journal of Lifestyle Medicine, September 1, 2008; 2(5): 421 - 431.
[Abstract] [PDF]


Home page
CirculationHome page
D. W. Jones, E. D. Peterson, R. O. Bonow, F. A. Masoudi, G. C. Fonarow, S. C. Smith Jr, P. Solis, M. Girgus, P. C. Hinton, A. Leonard, et al.
Translating Research Into Practice for Healthcare Providers: The American Heart Association's Strategy for Building Healthier Lives, Free of Cardiovascular Diseases and Stroke
Circulation, August 5, 2008; 118(6): 687 - 696.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. J. Blaha, S. Bansal, R. Rouf, S. H. Golden, R. S. Blumenthal, and A. P. DeFilippis
A Practical 'ABCDE' Approach to the Metabolic Syndrome
Mayo Clin. Proc., August 1, 2008; 83(8): 932 - 943.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Greenland and D. Lloyd-Jones
Defining a Rational Approach to Screening for Cardiovascular Risk in Asymptomatic Patients
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 330 - 332.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Suk Danik, N. Rifai, J. E. Buring, and P. M. Ridker
Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
J. Am. Coll. Cardiol., July 8, 2008; 52(2): 124 - 131.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. Matyal
Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management: A Core Review
Anesth. Analg., July 1, 2008; 107(1): 37 - 50.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Mosca
Aspirin Chemoprevention: One Size Does Not Fit All
Circulation, June 3, 2008; 117(22): 2844 - 2846.
[Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
S. S. Bassuk and J. E. Manson
Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence
American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 191 - 213.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum
n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. Barrios, C. Escobar, R. Echarri, and A. Matali
Gender and Blood Pressure Control
Hypertension, June 1, 2008; 51(6): e48 - e48.
[Full Text] [PDF]


Home page
CirculationHome page
D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong
Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation, May 13, 2008; 117(19): 2544 - 2565.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al.
Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care
Diabetes Care, May 1, 2008; 31(5): 1060 - 1079.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. K. Wenger
Current Status of Cardiac Rehabilitation
J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1619 - 1631.
[Abstract] [Full Text] [PDF]


Home page
Menopause IntHome page
G. Jackson
Gender differences in cardiovascular disease prevention
Menopause Int, March 1, 2008; 14(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
Menopause IntHome page
M. Rees, J. Stevenson, and on behalf of the British Menopause Society Council
Primary prevention of coronary heart disease in women
Menopause Int, March 1, 2008; 14(1): 40 - 45.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. G. Lakoski, P. Greenland, N. D. Wong, P. J. Schreiner, D. M. Herrington, R. A. Kronmal, K. Liu, and R. S. Blumenthal
Coronary Artery Calcium Scores and Risk for Cardiovascular Events in Women Classified as "Low Risk" Based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis (MESA)
Arch Intern Med, December 10, 2007; 167(22): 2437 - 2442.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Thomas, M. King, K. Lui, N. Oldridge, I. L. Pina, J. Spertus, R. O. Bonow, N.A. M. Estes III, D. C. Goff, K. L. Grady, et al.
AACVPR/ACC/AHA 2007 Performance Measures on Cardiac Rehabilitation for Referral to and Delivery of Cardiac Rehabilitation/Secondary Prevention Services: Endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1400 - 1433.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. E. Manson and S. S. Bassuk
Invited Commentary: Hormone Therapy and Risk of Coronary Heart Disease Why Renew the Focus on the Early Years of Menopause?
Am. J. Epidemiol., September 1, 2007; 166(5): 511 - 517.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
G. D. Harris
A 52-Year-Old Woman With Hypertension and Diabetes Who Presents With Chest Pain
Clin. Diabetes, July 1, 2007; 25(3): 115 - 118.
[Full Text] [PDF]


Home page
DOC NewsHome page
E. T. Beckley
Women Need Tailored CHD Prevention
DOC News, June 1, 2007; 4(6): 5 - 5.
[Full Text]


Home page
JAMAHome page
M. S. Lauer
Primary Prevention of Atherosclerotic Cardiovascular Disease: The High Public Burden of Low Individual Risk
JAMA, March 28, 2007; 297(12): 1376 - 1378.
[Full Text] [PDF]